Administrative Supplement to Watnick U54DK126114
Watnick U54DK126114 的行政补充
基本信息
- 批准号:10688699
- 负责人:
- 金额:$ 5.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-24 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdministrative SupplementAntibodiesAreaBaltimoreBasic ScienceBiomedical ResearchCell Culture TechniquesClinicalCollaborationsCommunitiesCountryDisciplineDiseaseDisease ProgressionEnd stage renal failureFutureGenerationsGoalsInstitutionInterdisciplinary StudyKnowledgeLeadershipMarylandMissionNational Institute of Diabetes and Digestive and Kidney DiseasesPolycystic Kidney DiseasesReagentResearchResearch PersonnelResourcesScienceSignal TransductionStretchingStudentsTherapeuticTherapeutic AgentsTranslational ResearchTranslationsUniversitiesVisionbasebiobankcellular engineeringclinical investigationclinical translationexperienceinnovationinterdisciplinary collaborationmedical schoolsmouse modelpreventprospectiveside effectsuccesstherapeutic targetvector
项目摘要
Overall Project Summary
In this application we establish the Maryland Polycystic Kidney Disease (PKD) Research and Translation Core
Center (MPKD-RTCC). The mission of this Center is to facilitate translational and basic research in the field of
polycystic kidney disease and related disciplines by providing unique resources, reagents and expertise to a
broad base of investigators. This proposal capitalizes on a long tradition of PKD research by MPKD-RTCC
investigators who have been at the forefront of PKD science for the past two decades. The Center consists of
4 highly collaborative and integrated biomedical research cores that together will distribute an essential
“toolbox” of reagents and expertise tailored specifically to PKD research. The MPKD-RTCC cores include 1)
Antibody and Vector 2) Mouse Models and Biobank 3) Cell Culture and Engineering and 4) Clinical and
Translation. Each core addresses a critical need in the PKD research pipeline, stretching from basic to clinical
investigation. In addition, MPKD-RTCC core leaders will pioneer solutions to perceived needs among PKD
Researchers by expanding in innovative directions. We expect that this strategy will continue our proven track
record of supporting high impact science across the country. These activities will be organized by an
Administrative Core led by two experienced investigators who will leverage the resources of two outstanding
research institutions in Baltimore, the University of Maryland Baltimore (UMB) and the Johns Hopkins School
of Medicine. As a team they will drive the MPKD-RTCC’s fundamental commitment to the principle of
collaborative science by streamlining SOPs for sharing high quality reagents and expertise, by integrating our
the core’s activities and by coordinating collaboration with other RTCCs within the PKD Research Consortium.
The Center’s Specific Aims are: 1) To provide critical state of the art reagents and expertise to a national group
of PKD investigators 2) To provide critical state of the art reagents and expertise to non-PKD investigators in
order to remove barriers to PKD related research 3) To develop innovative reagents and resources that will
advance biomedical discoveries in the field of PKD 4) To drive collaboration between MPKD-RTCC Cores and
other RTCCs within the PKD Research Consortium and 5) To partner with other RTCCs, the consortium
steering committee including the NIDDK to achieve the overall goals of the PKD Research Consortium.
Through expanded interdisciplinary collaborations, we hope to catalyze the translation of biomedical
discoveries that will prevent progression of polycystic kidney disease and its consequences.
整体项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Terry J Watnick其他文献
Terry J Watnick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Terry J Watnick', 18)}}的其他基金
Maryland Polycystic Kidney Disease Research and Translation Core Center (MPKD-RTCC)
马里兰州多囊肾病研究与转化核心中心 (MPKD-RTCC)
- 批准号:
10693919 - 财政年份:2020
- 资助金额:
$ 5.68万 - 项目类别:
National Coordinating Center (NCC) for the Polycystic Kidney Disease (PKD) Research and Translation Core Centers
国家多囊肾病 (PKD) 研究和转化核心中心协调中心 (NCC)
- 批准号:
10218161 - 财政年份:2020
- 资助金额:
$ 5.68万 - 项目类别:
National Coordinating Center (NCC) for the Polycystic Kidney Disease (PKD) Research and Translation Core Centers
国家多囊肾病 (PKD) 研究和转化核心中心协调中心 (NCC)
- 批准号:
10687258 - 财政年份:2020
- 资助金额:
$ 5.68万 - 项目类别:
Maryland Polycystic Kidney Disease Research and Translation Core Center (MPKD-RTCC)
马里兰州多囊肾病研究与转化核心中心 (MPKD-RTCC)
- 批准号:
10231255 - 财政年份:2020
- 资助金额:
$ 5.68万 - 项目类别:
Maryland Polycystic Kidney Disease Research and Translation Core Center (MPKD-RTCC)
马里兰州多囊肾病研究与转化核心中心 (MPKD-RTCC)
- 批准号:
10058976 - 财政年份:2020
- 资助金额:
$ 5.68万 - 项目类别:
National Coordinating Center (NCC) for the Polycystic Kidney Disease (PKD) Research and Translation Core Centers
国家多囊肾病 (PKD) 研究和转化核心中心协调中心 (NCC)
- 批准号:
10058889 - 财政年份:2020
- 资助金额:
$ 5.68万 - 项目类别:
Maryland Polycystic Kidney Disease Research and Translation Core Center (MPKD-RTCC)
马里兰州多囊肾病研究与转化核心中心 (MPKD-RTCC)
- 批准号:
10456638 - 财政年份:2020
- 资助金额:
$ 5.68万 - 项目类别:
相似海外基金
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
$ 5.68万 - 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 5.68万 - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
$ 5.68万 - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
$ 5.68万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 5.68万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 5.68万 - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
$ 5.68万 - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
$ 5.68万 - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
$ 5.68万 - 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
- 批准号:
10806365 - 财政年份:2023
- 资助金额:
$ 5.68万 - 项目类别: